Referências

1. Anderson Carl, 2011, J Diabetes Sci Technol, V5, P433
2. [Anonymous], 2010, Rev. Saúde Pública, V44, P575, DOI 10.1590/S0034-89102010000300024
3. Arai RJ, 2017, ECANCERMEDICALSCIENC, V11, DOI 10.3332/ecancer.2017.738
4. Arai RJ, 2010, LANCET ONCOL, V11, P712, DOI 10.1016/S1470-2045(10)70168-6
5. Be Lo, 2009, CONFLICT INTEREST ME
6. CADMAN EC, 1994, ANN INTERN MED, V120, P401, DOI 10.7326/0003-4819-120-5-199403010-00009
7. Coronel E, 2015, INT J CLIN TRIALS, V2, P28, DOI [10.5455/2349-3259.ijct20150501, DOI 10.5455/2349-3259.IJCT20150501]
8. Croghan IT, 2015, CONTEMP CLIN TRIALS, V45, P270, DOI 10.1016/j.cct.2015.10.001
9. Denicoff AM, 2013, J ONCOL PRACT, V9, P267, DOI 10.1200/JOP.2013.001119
10. DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1
11. Economia, 2009, RANK CLIN HOSP AM LA
12. Guo Y, 2011, AM J PHYS MED REHAB, V90, P265, DOI [10.1097/PHM.0b013e3182063ba6, 10.1097/PHM.0b013e31820be1a4]
13. ICH GCP, GOOD CLIN PRACT
14. Malakoff D, 2008, SCIENCE, V322, P210, DOI 10.1126/science.322.5899.210
15. Ministerio da Saude, 2005, RED NAC PESQ CLIN HO
16. Ministerio da Saude, 2017, EV CIENC TECN IN SAU
17. Nathan D, 2001, NAT REV CANCER, V1, P240, DOI 10.1038/35106102
18. Primack BA, 2010, CTS-CLIN TRANSL SCI, V3, P186, DOI 10.1111/j.1752-8062.2010.00202.x
19. Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3
20. Rubin E, 2009, ISSUE BRIEFS ASS ACA, V24, P1
21. White L A, 2001, Ochsner J, V3, P22